Frequency and impact of KRAS mutation in early onset colorectal cancer.
Surgery Department, University Hospital 12 de Octubre, Madrid E-28041, Spain; Digestive Cancer Research Group, 12 de Octubre Research Institute, Madrid, Spain. Electronic address: josepereag@hotmail.com.
José
J
Perea
Digestive Cancer Research Group, 12 de Octubre Research Institute, Madrid E-28041, Spain.
María
M
Arriba
Pathology Department, University Hospital 12 de Octubre, Madrid E-28041, Spain.
Yolanda
Y
Rodríguez
Digestive Cancer Research Group, 12 de Octubre Research Institute, Madrid E-28041, Spain; Molecular Biology Laboratory, University Hospital 12 de Octubre, Madrid E-28041, Spain.
Daniel
D
Rueda
Molecular Medicine Unit, Biomedical Research Institute of Salamanca (IBSAL), Institute of Molecular and Cellular Biology of Cancer (IBMCC), University of Salamanca-USAL-CSIC, E-37008 Salamanca, Spain.
Juan Luis
JL
García
Biomedical Research Institute of Salamanca (IBSAL), Institute of Molecular and Cellular Biology of Cancer (IBMCC), University of Salamanca-USAL-CSIC, E-37008 Salamanca, Spain.
Jessica
J
Pérez
Biomedical Research Institute of Salamanca (IBSAL), Institute of Molecular and Cellular Biology of Cancer (IBMCC), University of Salamanca-USAL-CSIC, E-37008 Salamanca, Spain.
Rogelio
R
González-Sarmiento
Familial Cancer Clinical Unit, Spanish National Cancer Centre (CNIO), Madrid, Spain; Center for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.
Miguel
M
Urioste
D015179:Colorectal Neoplasms / Q000235:genetics; D006801:Humans; D009154:Mutation; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics*
D016283:Proto-Oncogene Proteins p21(ras)